Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Y Bouffard

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Leukemia Research|November 1, 1995
Comparison of the induction of apoptosis in human leukemic cell lines by 2',2'-difluorodeoxycytidine (gemcitabine) and cytosine arabinosideD Y Bouffard, R L Momparler
Biochemical Pharmacology|May 5, 1993
Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminaseD Y Bouffard, J Laliberté, R L Momparler
International Journal of Urology : Official Journal of the Japanese Urological Association|July 1, 1997
Ribozyme-mediated cancer gene therapyA Irie, D Y Bouffard, K J Scanlon
Anti-Cancer Drugs|February 1, 1991
Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cellsD Y Bouffard, L F Momparler, R L Momparler
Anti-Cancer Drugs|April 1, 1994
Enhancement of the antileukemic activity of 5-aza-2'-deoxycytidine by cyclopentenyl cytosine in HL-60 leukemic cellsD Y Bouffard, L F Momparler, R L Momparler
Pharmacology & Therapeutics|January 1, 1997
Oligonucleotides as modulators of cancer gene expressionL D Curcio, D Y Bouffard, K J Scanlon
Cancer Chemotherapy and Pharmacology|January 1, 1990
Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cellsR L Momparler, N Onetto-Pothier, D Y Bouffard, et al.
Anti-Cancer Drugs|April 1, 1997
Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancerR L Momparler, D Y Bouffard, L F Momparler, et al.
International Journal of Cancer|October 21, 1991
Enhancement of anti-neoplastic activity of cytosine arabinoside against human HL-60 myeloid leukemic cells by 3-deazauridineR L Momparler, D Y Bouffard, L F Momparler, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Oligonucleotide modulation of multidrug resistanceD Y Bouffard, T Ohkawa, H Kijima, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Leukemia Research|November 1, 1995
Comparison of the induction of apoptosis in human leukemic cell lines by 2',2'-difluorodeoxycytidine (gemcitabine) and cytosine arabinosideD Y Bouffard, R L Momparler
Biochemical Pharmacology|May 5, 1993
Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminaseD Y Bouffard, J Laliberté, R L Momparler
International Journal of Urology : Official Journal of the Japanese Urological Association|July 1, 1997
Ribozyme-mediated cancer gene therapyA Irie, D Y Bouffard, K J Scanlon
Anti-Cancer Drugs|February 1, 1991
Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cellsD Y Bouffard, L F Momparler, R L Momparler
Anti-Cancer Drugs|April 1, 1994
Enhancement of the antileukemic activity of 5-aza-2'-deoxycytidine by cyclopentenyl cytosine in HL-60 leukemic cellsD Y Bouffard, L F Momparler, R L Momparler
Pharmacology & Therapeutics|January 1, 1997
Oligonucleotides as modulators of cancer gene expressionL D Curcio, D Y Bouffard, K J Scanlon
Cancer Chemotherapy and Pharmacology|January 1, 1990
Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cellsR L Momparler, N Onetto-Pothier, D Y Bouffard, et al.
Anti-Cancer Drugs|April 1, 1997
Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancerR L Momparler, D Y Bouffard, L F Momparler, et al.
International Journal of Cancer|October 21, 1991
Enhancement of anti-neoplastic activity of cytosine arabinoside against human HL-60 myeloid leukemic cells by 3-deazauridineR L Momparler, D Y Bouffard, L F Momparler, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Oligonucleotide modulation of multidrug resistanceD Y Bouffard, T Ohkawa, H Kijima, et al.
Pageof 2